Dangerous Minds: Evidence-based migraine treatments - BCPMP

Course overview

0202-0000-26-198-H01-P Migraine is one of the most common and disabling neurological disorders worldwide, significantly affecting patient quality of life. With recent advances in pharmacologic and non-pharmacologic therapies, migraine treatment guidelines continue to evolve, expanding options for both acute and preventive care. This session will review current guideline recommendations, highlight emerging therapies, and provide pharmacists with practical strategies for applying evidence-based approaches to optimize migraine management in various practice settings.